Hudson, Melissa M <br/><br/>
Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Nov 2004 
 - 4541-50 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2004.02.139  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Child<br/>Child, Preschool<br/>Combined Modality Therapy<br/>Cyclophosphamide--administration & dosage<br/>Disease Progression<br/>Disease-Free Survival<br/>Doxorubicin--administration & dosage<br/>Female<br/>Hodgkin Disease--drug therapy<br/>Humans<br/>Male<br/>Methotrexate--administration & dosage<br/>Prednisone--administration & dosage<br/>Procarbazine--administration & dosage<br/>Prognosis<br/>Risk Assessment<br/>Treatment Outcome<br/>Vinblastine--administration & dosage